Importer of Controlled Substances Application: Xcelience, 32279 [2021-12816]
Download as PDF
<![CDATA[
32279
Federal Register / Vol. 86, No. 115 / Thursday, June 17, 2021 / Notices
purposes of this Investigation may be
disclosed to and used: (i) By the
Commission, its employees and Offices,
and contract personnel (a) for
developing or maintaining the records
of this or a related proceeding, or (b) in
internal investigations, audits, reviews,
and evaluations relating to the
programs, personnel, and operations of
the Commission including under 5
U.S.C. Appendix 3; or (ii) by U.S.
government employees and contract
personnel,2 solely for cybersecurity
purposes. All nonconfidential written
submissions will be available for public
inspection at the Office of the Secretary
and on EDIS.3
This action is taken under the
authority of section 337 of the Tariff Act
of 1930, as amended (19 U.S.C. 1337),
and of §§ 201.10 and 210.8(c) of the
Commission’s Rules of Practice and
Procedure (19 CFR 201.10, 210.8(c)).
Drug Enforcement Administration
Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before July 19, 2021. Such persons
may also file a written request for a
hearing on the application on or before
July 19, 2021.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing must
be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All requests for a
hearing should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/OALJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DPW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In
accordance with 21 CFR 1301.34(a), this
is notice that on April 28, 2021,
Xcelience, 4901 West Grace Street,
Tampa, Florida 33607–3805, applied to
be registered as an importer of the
following basic class(es) of controlled
substance(s):
[Docket No. DEA–854]
Controlled substance
Drug code
Importer of Controlled Substances
Application: Xcelience
Psilocybin ................
7437
By order of the Commission.
Issued: June 11, 2021.
Lisa Barton,
Secretary to the Commission.
[FR Doc. 2021–12811 Filed 6–16–21; 8:45 am]
BILLING CODE 7020–02–P
DEPARTMENT OF JUSTICE
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
Xcelience has applied to be
registered as an importer of basic
class(es) of controlled substance(s).
Refer to Supplementary Information
listed below for further drug
information.
SUMMARY:
DATES:
Schedule
I
The company plans to import drug
code 7437 (Psilocybin) as finished
dosage form for clinical trials, research,
and analytical purposes.
Approval of permit applications will
occur only when the registrant’s
business activity is consistent with what
is authorized under 21 U.S.C. 952(a)(2).
Authorization will not extend to the
import of Food and Drug
Administration-approved or non-
approved finished dosage forms for
commercial sale.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2021–12816 Filed 6–16–21; 8:45 am]
BILLING CODE P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–855]
Bulk Manufacturer of Controlled
Substances Application: Organix Inc.
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
Organix Inc. has applied to be
registered as a bulk manufacturer of
basic class(es) of controlled
substance(s). Refer to Supplemental
Information listed below for further
drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before August 16, 2021. Such persons
may also file a written request for a
hearing on the application on or before
August 16, 2021.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152.
SUMMARY:
In
accordance with 21 CFR 1301.33(a), this
is notice that on April 27, 2021, Organix
Inc., 240 Salem Street, Woburn,
Massachusetts 01801–2029, applied to
be registered as an bulk manufacturer of
the following basic class(es) of
controlled substance(s):
SUPPLEMENTARY INFORMATION:
Controlled substance
Drug code
lotter on DSK11XQN23PROD with NOTICES1
Mescaline .........................................................................................................................................................................
3,4,5-trimethoxyamphetamine .........................................................................................................................................
4-bromo-2,5-dimethoxyphenethylamine ..........................................................................................................................
3,4-methylenedioxyamphetamine ....................................................................................................................................
3,4-methylenedioxymethamphetamine ............................................................................................................................
2-(2,5-dimethoxyphenyl)ethanamine ...............................................................................................................................
2-(4-Iodo-2,5-dimethoxyphenyl)ethanamine ....................................................................................................................
2 All contract personnel will sign appropriate
nondisclosure agreements.
VerDate Sep<11>2014
18:41 Jun 16, 2021
Jkt 253001
3 Electronic Document Information System
(EDIS): https://edis.usitc.gov.
PO 00000
Frm 00036
Fmt 4703
Sfmt 4703
E:\FR\FM\17JNN1.SGM
17JNN1
7381
7390
7392
7400
7405
7517
7518
Schedule
I
I
I
I
I
I
I
]]>Agencies
[Federal Register Volume 86, Number 115 (Thursday, June 17, 2021)]
[Notices]
[Page 32279]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-12816]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-854]
Importer of Controlled Substances Application: Xcelience
AGENCY: Drug Enforcement Administration, Justice.
ACTION: Notice of application.
-----------------------------------------------------------------------
SUMMARY: Xcelience has applied to be registered as an importer of basic
class(es) of controlled substance(s). Refer to Supplementary
Information listed below for further drug information.
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefore, may file written comments on or objections to
the issuance of the proposed registration on or before July 19, 2021.
Such persons may also file a written request for a hearing on the
application on or before July 19, 2021.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DPW,
8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a
hearing must be sent to: Drug Enforcement Administration, Attn:
Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All
requests for a hearing should also be sent to: (1) Drug Enforcement
Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive,
Springfield, Virginia 22152; and (2) Drug Enforcement Administration,
Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive,
Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this
is notice that on April 28, 2021, Xcelience, 4901 West Grace Street,
Tampa, Florida 33607-3805, applied to be registered as an importer of
the following basic class(es) of controlled substance(s):
------------------------------------------------------------------------
Controlled substance Drug code Schedule
------------------------------------------------------------------------
Psilocybin........................... 7437 I
------------------------------------------------------------------------
The company plans to import drug code 7437 (Psilocybin) as finished
dosage form for clinical trials, research, and analytical purposes.
Approval of permit applications will occur only when the
registrant's business activity is consistent with what is authorized
under 21 U.S.C. 952(a)(2). Authorization will not extend to the import
of Food and Drug Administration-approved or non-approved finished
dosage forms for commercial sale.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2021-12816 Filed 6-16-21; 8:45 am]
BILLING CODE P
